Abstract P102 – Table 1. Percentage of patients that stopped therapy after one year and the reason to stop as percentage of the total 687 patients.
Patients with one‐year of follow‐up	n=687	Percentage
Continued	593	86.3%
Stopped	94	13.7%
Reason to stop
Virologic failure	4	0.6
Resistance ‐ V106A	1	0.1%
Incompliance	1	0.1%
Unknown	2	0.3%
Medical reason	11	1.6%
Patient‐reported adverse eventa	70	10.2%
Insomnia	17	2.5%
Psychological symptoms	17	2.5%
Gastro‐intestinal	20	2.9%
Musculoskeletal	11	1.6%
Possible allergic skin reactions	8	1.2%
Other skin reactions	6	0.9%
Other	8	1.2%

^aFirst row demonstrates the total number of patients followed by the categories of adverse events. Some patients had more than one adverse event as reason to stop.